The Discounted Cash Flow (DCF) valuation of Biogen Inc (BIIB) is 231.05 USD. With the latest stock price at 188.74 USD, the upside of Biogen Inc based on DCF is 22.4%.
| Range | Selected | |
| WACC / Discount Rate | 7.5% - 10.2% | 8.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 152.08 - 460.61 | 231.05 |
| Upside | -19.4% - 144.0% | 22.4% |